Actively Recruiting
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
Led by Mayo Clinic · Updated on 2025-12-16
40
Participants Needed
1
Research Sites
264 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fear of cancer coming back, progression of the cancer, and uncertainty of the future. These distresses impair patients' well-being and quality of life (QOL) in general, and their cancer treatment adherence and effectiveness in particular. Meditation has been demonstrated to be an effective management tool of stress and anxiety and is given the highest level of evidence (grade A) in the systematic review-based guidelines by the Society of Integrative Medicine. The portable, interactive, electroencephalographic (EEG) Muse headband guided meditation has been shown to improve fatigue, QOL, and stress in newly diagnosed breast cancer patients. The MUSE-S Headband System may decrease anxiety and insomnia among breast cancer survivors.
CONDITIONS
Official Title
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Diagnosed with stage 1 to 4 breast cancer in the past 10 years
- Report anxiety and insomnia both rated above 3 on a 0 to 10 scale at enrollment
- Stable dose of anti-anxiety or anti-depressant medication for at least 1 month before enrollment and throughout the study
- Own a smartphone or tablet
- Willing to use a Google-based anonymous email account to sign up for MUSE
- Able and willing to provide informed consent and complete all study activities
- No health conditions that would prevent proper use of the MUSE-S system as determined by investigators
You will not qualify if you...
- Pregnant or breastfeeding
- Used regular mindfulness practice or integrative medicine therapies (e.g., acupuncture, mindfulness, massage, energy therapies) within 60 days
- Currently taking medication for insomnia
- Unstable medical or mental health condition as determined by the oncologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here